Randomized phase II study comparing the efficacy and safety of SOX versus mFOLFOX6 as neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer (KSCC1301)

被引：0

作者：

Keisuke Miwa

Eiji Oki

Masanobu Enomoto

Keisuke Ihara

Koji Ando

Fumihiko Fujita

Masahiro Tominaga

Shinichiro Mori

Goro Nakayama

Mototsugu Shimokawa

Hiroshi Saeki

Hideo Baba

Masaki Mori

Yoshito Akagi

机构：

[1] Kurume University Hospital,Multidisciplinary Treatment Cancer Center

[2] Kyushu University,Department of Surgery and Science, Graduate School of Medical Sciences

[3] Tokyo Medical University,Gastrointestinal and Pediatric Surgery

[4] Dokkyo Medical University,First Department of Surgery

[5] Kurume University School of Medicine,Department of Surgery

[6] Department of Gastroenterological Surgery,Department of Digestive Surgery, Breast and Thyroid Surgery

[7] Hyogo Cancer Center,Department of Gastroenterological Surgery, Graduate School of Medicine

[8] Kagoshima University,Cancer Biostatistics Laboratory, Clinical Research Institute

[9] Nagoya University,Department of Biostatistics

[10] National Hospital Organization Kyusyu Cancer Center,Department of Gastroenterological Surgery

[11] Yamaguchi University Graduate School of Medicine,Department of Gastroenterological Surgery

[12] Gunma University Graduate School of Medicine,undefined

[13] Kumamoto University Graduate School of Medicine,undefined

来源：

BMC Cancer | / 21卷

关键词：

Rectal cancer; Neoadjuvant chemotherapy; Chemoradiotherapy; SOX; mFOLFOX6;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[21] A multicenter phase II study on the feasibility and efficacy of neoadjuvant chemotherapy for locally advanced rectal cancer.
Goto, Saori
Hasegawa, Suguru
Matsumoto, Takuya
Hida, Koya
Kawamura, Junichiro
Yamanokuchi, Satoshi
Yamaguchi, Takashi
Matsusue, Ryo
Kadokawa, Yoshio
Kato, Shigeru
Manaka, Dai
Nishitai, Ryuta
Nomura, Akinari
Kanazawa, Akiyoshi
Kawada, Kenji
Kyogoku, Takahisa
Sakai, Yoshiharu
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
[22] mFOLFOX6 versus mFOLFOX6 D aflibercept as neoadjuvant treatment in MRI-defined T3-rectal cancer: a randomized phase-II-trial of the German Rectal Cancer Study Group (CAO/ARO/AIO 0214)
Hofheinz, R. -D.
Herrle, F.
Dechow, T.
von Weikersthal, L. F.
Welslau, M.
Lettmaier, S.
Burkart, C.
Kubicka, S.
Kochen, L.
Merx, K.
Krause, K.
Ebert, M.
Roedel, C.
Fokas, E.
Ghadimi, M.
Reissfelder, C.
Gaiser, T.
ESMO OPEN, 2024, 9 (09)
[23] Neoadjuvant Chemotherapy With/Without Radiotherapy for Locally Advanced Rectal Cancer: A Nationwide Retrospective Cohort Study
Ke, Tao-wei
Chang, Sheng-chi
Liao, Yu-min
Lin, Che-hung
Chen, William tzu-liang
Liang, Ji-an
Li, Chia-chin
Chen, Chun-ru
ANTICANCER RESEARCH, 2023, 43 (12) : 5713 - 5722
[24] Consolidation mFOLFOX6 Chemotherapy After Chemoradiotherapy Improves Survival in Patients With Locally Advanced Rectal Cancer: Final Results of a Multicenter Phase II Trial
Marco, Michael R.
Zhou, Lihong
Patil, Sujata
Marcet, Jorge E.
Varma, Madhulika G.
Oommen, Samuel
Cataldo, Peter A.
Hunt, Steven R.
Kumar, Anjali
Herzig, Daniel O.
Fichera, Alessandro
Polite, Blase N.
Hyman, Neil H.
Ternent, Charles A.
Stamos, Michael J.
Pigazzi, Alessio
Dietz, David
Yakunina, Yuliya
Pelossof, Raphael
Garcia-Aguilar, Julio
DISEASES OF THE COLON & RECTUM, 2018, 61 (10) : 1146 - 1155
[25] Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: Results of a phase II study
Caravatta, Luciana
Padula, Gilbert D. A.
Picardi, Vincenzo
Macchia, Gabriella
Deodato, Francesco
Massaccesi, Mariangela
Sofo, Luigi
Pacelli, Fabio
Rotondi, Fabio
Cecere, Giuseppe
Sallustio, Giuseppina
Di Lullo, Liberato
Piscopo, Adele
Mignogna, Samantha
Bonomo, Pierluigi
Cellini, Numa
Valentini, Vincenzo
Morganti, Alessio G.
ACTA ONCOLOGICA, 2011, 50 (08) : 1151 - 1157
[26] A PHASE II STUDY OF CONCURRENT PREOPERATIVE CHEMOTHERAPY AND RADIOTHERAPY ON LOCALLY ADVANCED RECTAL CANCER
Khalaf, Marwa
Eid, Samir
Hamza, Hesham
ANNALS OF ONCOLOGY, 2012, 23 : 111 - 111
[27] Preoperative Concurrent Chemoradiotherapy Versus Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: Phase II Randomized Study
Wang, Xin
Zhao, Dong-Bing
Yang, Lin
Chi, Yihebali
Zhao, Hong
Jiang, Li-Ming
Jiang, Jun
Tang, Yuan
Li, Ning
Liu, Wen-Yang
Dou, Li-Zhou
Zou, Shuang-Mei
Xue, Li-Yan
Ren, Jian-Song
Tian, Yan-Tao
Che, Xu
Guo, Chun-Guang
Bai, Xiao-Feng
Sun, Yue-Min
Wang, Shu-Lian
Song, Yong-Wen
Liu, Yue-Ping
Fang, Hui
Li, Ye-Xiong
Jin, Jing
FRONTIERS IN ONCOLOGY, 2022, 12
[28] The efficacy and safety of neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer: A randomized multicenter study
Yang, Zhijun
Chen, Dandan
Zhang, Jieqing
Yao, Desheng
Gao, Kun
Wang, He
Liu, Cui
Yu, Jiang
Li, Li
GYNECOLOGIC ONCOLOGY, 2016, 141 (02) : 231 - 239
[29] The efficacy and safety of short-course radiotherapy followed by sequential chemotherapy and Cadonilimab for locally advanced rectal cancer: a protocol of a phase II study
Xu, Tongzhen
Feng, Lingling
Zhang, Wenjue
Li, Haoyue
Ma, Huiying
Abulimiti, Muyasha
Tan, Yutong
Deng, Feiyan
Huang, Wenting
Zou, Shuangmei
Kang, Wenyan
Jiang, Liming
Wang, Ying
Hu, Chen
Chen, Yinggang
Zhou, Haitao
Tang, Yuan
Jin, Jing
BMC CANCER, 2024, 24 (01)
[30] Perioperative chemotherapy with mFOLFOX6 or CAPOX for patients with locally advanced colon cancer (OPTICAL): A multicenter, randomized, phase 3 trial.
Hu, Huabin
Huang, Meijin
Li, Yunfeng
Wang, Ziqiang
Wang, Xiaozhong
Liu, Ping
Zhang, Ruyi
Zhang, Hao
Huang, Zhongcheng
Pei, Haiping
Zeng, Yongming
Lai, Jiajun
Chen, Wenbin
Chen, Jiansi
Ding, Zhijie
Wei, Hongbo
Xu, Qingwen
Chen, Jigui
Wang, Jianping
Deng, Yanhong
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)

← 1 2 3 4 5 →